Marshall Wace’s Alnylam Pharmaceuticals ALNY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $77.8M | Sell |
238,573
-30,359
| -11% | -$9.9M | 0.09% | 199 |
|
|
2025
Q1 | $72.6M | Sell |
268,932
-109,717
| -29% | -$29.6M | 0.09% | 175 |
|
|
2024
Q4 | $89.1M | Buy |
378,649
+315,182
| +497% | +$74.2M | 0.11% | 167 |
|
|
2024
Q3 | $17.5M | Buy |
+63,467
| New | +$17.5M | 0.02% | 504 |
|
|
2024
Q1 | – | Sell |
-1,300
| Closed | -$249K | – | 2090 |
|
|
2023
Q4 | $249K | Buy |
+1,300
| New | +$249K | ﹤0.01% | 1618 |
|
|
2023
Q3 | – | Sell |
-11,085
| Closed | -$2.11M | – | 1810 |
|
|
2023
Q2 | $2.11M | Buy |
+11,085
| New | +$2.11M | ﹤0.01% | 1136 |
|
|
2022
Q3 | – | Sell |
-165,292
| Closed | -$24.1M | – | 2516 |
|
|
2022
Q2 | $24.1M | Buy |
+165,292
| New | +$24.1M | 0.05% | 350 |
|
|
2021
Q4 | – | Sell |
-16,427
| Closed | -$3.1M | – | 3118 |
|
|
2021
Q3 | $3.1M | Buy |
+16,427
| New | +$3.1M | 0.01% | 1023 |
|
|
2020
Q3 | – | Sell |
-58,231
| Closed | -$8.63M | – | 1509 |
|
|
2020
Q2 | $8.63M | Buy |
+58,231
| New | +$8.63M | 0.06% | 305 |
|
|
2019
Q3 | – | Sell |
-234,539
| Closed | -$17M | – | 1606 |
|
|
2019
Q2 | $17M | Buy |
+234,539
| New | +$17M | 0.14% | 157 |
|
|
2016
Q3 | – | Sell |
-34,727
| Closed | -$1.93M | – | 928 |
|
|
2016
Q2 | $1.93M | Buy |
+34,727
| New | +$1.93M | 0.02% | 585 |
|
|
2014
Q3 | – | Sell |
-5,000
| Closed | -$316K | – | 861 |
|
|
2014
Q2 | $316K | Buy |
+5,000
| New | +$316K | ﹤0.01% | 749 |
|